EHAB

MKT CAP:$704M

Enhabit, Inc.

Market Cap

$704M

Healthcare·Medical - Care Facilities·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$13.73+$4.64 (+51.05%)

Apr 22, 2026

Company Details

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical adm...

CEO

Barbara Ann Jacobsmeyer

IPO Date

Jun 23, 2022

Website

www.ehab.com

Key Metrics TTM

Revenue

$1.0B

-3.6% YoY

Net Income

-$52M

EPS (Diluted)

-$1.05

Free Cash Flow

$20M

Revenue / Share

$20.75

Gross Margin

46.7%

Operating Margin

-1.2%

Net Margin

-5.0%

FCF Margin

1.9%

P/S

0.7x

P/E

—

Earnings Reports

Q1 2025

May 6, 2026

PENDING

Q4 2024

Mar 6, 2025

$258M-0.9%EPS -$0.92

Q2 2024

Aug 8, 2024

$261M-0.6%EPS -$0.00

Q1 2024

May 9, 2024

$262MEPS $0.00

FY 2023

Apr 26, 2024

$1.0BEPS -$1.61

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 21	$286M	$157M	$41M
Q4 21	$276M	$148M	$36M
Q1 22	$274M	$145M	$35M
Q2 22	$268M	$138M	$27M
Q2 23	$262M	$127M	-$75M
Q4 23	$261M	$119M	$5M
Q1 24	$262M	$120M	$13M
Q2 24	$261M	$121M	$11M
Q4 24	$258M	$125M	-$41M

Valuation

Quarter	P/S	P/E
Q2 21	—	—
Q4 21	—	—
Q1 22	—	—
Q2 22	0.6x	6.5x
Q2 23	0.7x	639.6x
Q4 23	0.7x	—
Q1 24	0.7x	—
Q2 24	0.7x	—
Q4 24	0.7x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 21	$73M	$72M
Q4 21	$23M	$23M
Q1 22	$41M	$39M
Q2 22	$34M	$31M
Q2 23	$10M	$9M
Q4 23	$800.0K	$400.0K
Q1 24	$17M	$16M
Q2 24	$10M	$9M
Q4 24	-$4M	-$5M

Capital Expenditures

Quarter	CapEx
Q2 21	$1M
Q4 21	$400.0K
Q1 22	$2M
Q2 22	$2M
Q2 23	$1M
Q4 23	$400.0K
Q1 24	$2M
Q2 24	$700.0K
Q4 24	$600.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 23	-8.3%	+37.6%
Q4 23	-5.6%	+6.3%
Q1 24	-4.3%	+4.4%
Q2 24	-2.8%	+3.6%
Q4 24	-1.6%	-11.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 21	$0	0.0%
Q4 21	$0	0.0%
Q1 22	$0	0.0%
Q2 22	$0	0.0%
Q2 23	$3M	1.0%
Q4 23	$0	0.0%
Q1 24	$2M	0.7%
Q2 24	$2M	0.8%
Q4 24	$4M	1.5%

OpEx Breakdown

Quarter	G&A
Q2 21	$106M
Q4 21	$103M
Q1 22	$101M
Q2 22	$102M
Q2 23	$108M
Q4 23	$115M
Q1 24	$108M
Q2 24	$110M
Q4 24	$105M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$18M	$0	$18M
Q2 22	$50M	$0	$50M
Q3 22	$44M	$0	$44M
Q4 22	$23M	$0	$23M
Q1 23	$38M	$0	$38M
Q2 23	$34M	$0	$34M
Q3 23	$32M	$0	$32M
Q4 23	$27M	$0	$27M
Q1 24	$37M	$0	$37M
Q2 24	$29M	$0	$29M
Q3 24	$46M	$0	$46M
Q4 24	$28M	$0	$28M
Q1 25	$40M	$0	$40M
Q2 25	$37M	$0	$37M
Q3 25	$57M	$0	$57M
Q4 25	$44M	$0	$44M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 21	50M	—	—
Q4 21	50M	0.0%	—
Q1 22	50M	0.0%	—
Q2 22	50M	-0.6%	—
Q2 23	50M	+0.4%	-0.2%
Q4 23	50M	+0.4%	+0.2%
Q1 24	50M	+0.8%	+1.0%
Q2 24	50M	-0.6%	+1.0%
Q4 24	50M	+0.2%	+0.8%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 21	—	—
Q4 21	—	—
Q1 22	—	—
Q2 22	—	—
Q2 23	$23.8K	11K
Q4 23	$24.1K	11K
Q1 24	$24.3K	11K
Q2 24	$24.1K	11K
Q4 24	$24.1K	11K

Revenue / Employee